FDA
approval
· 2022-11-08
FDA Approved: QUVIVIQ — Supplemental Application (Idorsia Pharmaceuticals Ltd)
Summary
FDA approved a supplemental application for QUVIVIQ (daridorexant) from Idorsia Pharmaceuticals Ltd, updating the product labeling for the treatment of insomnia…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for QUVIVIQ (DARIDOREXANT)